EDGAR Filing Documents for 0001628280-24-008062

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001628280-24-008062

Filing Date

2024-02-29

Accepted

2024-02-29 17:20:16

Documents

Effectiveness Date

2024-02-29

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	zentalis-sx8.htm	S-8	75434
2	EX-FILING FEES	zentalisexhibit107-sx8.htm	EX-FILING FEES	23470
3	EX-5.1	zentalis-exhibit51xsx8.htm	EX-5.1	20277
4	EX-23.1	zentalisexhibit231-sx8.htm	EX-23.1	2809
5		lathama.jpg	GRAPHIC	77458
6		logo1aa.jpg	GRAPHIC	106869
	Complete submission text file	0001628280-24-008062.txt		377097

Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018

Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791

Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277550 | Film No.: 24705180
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)